Literature DB >> 7248294

A system of DNA replication in HeLa nuclei treated with inhibitors of protein synthesis.

K Nagata, T Enomoto, M A Yamada.   

Abstract

An in vitro DNA synthesizing system consisting os isolated nuclei from HeLa cells which had been treated with inhibitors of protein synthesis was investigated. Treatment with both 30 microgram/ml cycloheximide and 10 microgram/ml puromycin of S-phase cells reduced the rate of DNA synthesis immediately; however, the overall DNA synthesis continued for up to 4 h with a diminished rate and then ceased. In the nuclei which were isolated from the cells which had been incubated with these drugs for 6 h, little incorporation of [3H]TTP into acid-insoluble materials was observed. Addition of cytosol prepared from cells actively synthesizing DNA induced the incorporation of [3H]TTP in these nuclei, while little induction was observed by the addition of cytosol prepared from drug-treated cells in spite of the fact that the latter cytosol stimulated DNA synthesis in isolated nuclei from non-treated cells. The induced DNA synthesis was shown to require Mg2+, all four deoxyribonucleoside triphosphates and ATP, and to proceed discontinuously. The activity inducing DNA synthesis in drug-treated nuclei fluctuated with the phases in a cell cycle and it was not ascribed solely to DNA polymerase alpha nor to DNA ligase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7248294     DOI: 10.1016/0005-2787(81)90188-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Isolated HeLa cell nuclei synthesize meaningful DNA.

Authors:  T Kristensen; H Prydz
Journal:  Nucleic Acids Res       Date:  1985-05-24       Impact factor: 16.971

2.  Distinct mechanistic responses to replication fork stalling induced by either nucleotide or protein deprivation.

Authors:  Sofia Henriksson; Petra Groth; Nina Gustafsson; Thomas Helleday
Journal:  Cell Cycle       Date:  2018-04-02       Impact factor: 4.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.